Annual Working Capital
-$6.44 M
-$2.74 M-73.87%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual working capital is -$6.44 million, with the most recent change of -$2.74 million (-73.87%) on December 31, 2023.
- During the last 3 years, CHRO annual working capital has fallen by -$2.87 million (-80.12%).
- CHRO annual working capital is now -149.76% below its all-time high of -$2.58 million, reached on December 1, 2021.
Performance
CHRO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$1.43 M
-$1.24 M-682.10%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly working capital is -$1.43 million, with the most recent change of -$1.24 million (-682.10%) on September 30, 2024.
- Over the past year, CHRO quarterly working capital has increased by +$5.02 million (+77.85%).
- CHRO quarterly working capital is now -226.31% below its all-time high of $1.13 million, reached on March 31, 2024.
Performance
CHRO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CHRO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.9% | +77.8% |
| 3 y3 years | -80.1% | +52.5% |
| 5 y5 years | -80.1% | +52.5% |
CHRO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -149.8% | at low | -226.3% | +77.8% |
| 5 y | 5-year | -149.8% | at low | -226.3% | +77.8% |
| alltime | all time | -149.8% | at low | -226.3% | +77.8% |
Chromocell Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.43 M(+682.1%) |
| Jun 2024 | - | -$182.52 K(-116.2%) |
| Mar 2024 | - | $1.13 M(-117.5%) |
| Dec 2023 | -$6.44 M | -$6.44 M(+9.1%) |
| Sep 2023 | - | -$5.90 M(+20.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$4.90 M(+11.4%) |
| Mar 2023 | - | -$4.40 M(+18.7%) |
| Dec 2022 | -$3.71 M(+43.6%) | -$3.71 M(+23.2%) |
| Sep 2022 | - | -$3.01 M(+16.6%) |
| Dec 2021 | -$2.58 M(-27.9%) | -$2.58 M |
| Dec 2020 | -$3.58 M | - |
FAQ
- What is Chromocell Therapeutics annual working capital?
- What is the all time high annual working capital for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual working capital year-on-year change?
- What is Chromocell Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly working capital year-on-year change?
What is Chromocell Therapeutics annual working capital?
The current annual working capital of CHRO is -$6.44 M
What is the all time high annual working capital for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual working capital is -$2.58 M
What is Chromocell Therapeutics annual working capital year-on-year change?
Over the past year, CHRO annual working capital has changed by -$2.74 M (-73.87%)
What is Chromocell Therapeutics quarterly working capital?
The current quarterly working capital of CHRO is -$1.43 M
What is the all time high quarterly working capital for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly working capital is $1.13 M
What is Chromocell Therapeutics quarterly working capital year-on-year change?
Over the past year, CHRO quarterly working capital has changed by +$5.02 M (+77.85%)